Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia: A 6-Year Prospective Cohort Study

Medicine & Life Sciences

• 1,25-dihydroxyergocalciferol 20%
• alfacalcidol 16%
• Bone and Bones 38%
• Bone Density 58%
• Bone Remodeling 65%
• Bone Resorption 10%
• Calcium 7%
• calcium phosphate 23%
• Child 4%
• Cohort Studies 43%
• Familial Hypophosphatemic Rickets 100%
• Fibroblast Growth Factor 1 14%
• fibroblast growth factor 23 29%
• Hip 8%
• Homeostasis 7%
• Linear Models 16%
• Osteomalacia 14%
• Pelvic Bones 27%
• Phosphates 9%
• Prospective Studies 40%
• Renal Reabsorption 14%
• Rickets 13%
• Spine 24%
• Therapeutics 10%